Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it doesn’t work.
U.S. FDA proposes ending use of popular decongestant present in cold medicines
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective,
FDA says commonly used decongestant 'not effective,' proposes removal
Nov. 7 (UPI) --The U.S. Food and
Drug
Administration has determined commonly used oral phenylephrine is "not effective" and has proposed its removal from over-the-counter nasal decongestants. "It is the
FDA
's role to ensure that drugs are safe and ...
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter (OTC) nasal decongestants, citing concerns over its effectiveness. After reviewing available data,
FDA proposes ending use of decongestant found in many cold, allergy medicines
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.
FDA proposes pulling ineffective cold medicine from shelves
When you're feeling under the weather, you likely grab your go-to cough and cold medicine. But are all the ingredients helping you fight off that cold?
FDA Claims Ingredients In Cold Medicines Is Ineffective
FDA Claims Ingredients In Cold Medicines Is Ineffective
The FDA Is Finally Pulling a Useless Cold Medicine From the Market
Phenylephrine is both the most common decongestant on pharmacy shelves, and arguably the worst at its job. Last year, the FDA's advisory panel ruled it should no longer be considered an effective drug.
FDA proposes pulling decongestants from shelves over ingredient
Just as cold and flu season arrives, the Food and Drug Administration proposes pulling many decongestants from store shelves.
Yahoo
4h
What is oral phynylephrine and why does the FDA want to remove it from cold medicine?
The U.S. Food and
Drug
Administration (
FDA
) is proposing to remove a common ingredient in nasal decongestants used by ...
2d
on MSN
FDA to pull common but ineffective cold medicine from market
The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...
Hosted on MSN
18h
These Over-The-Counter Decongestants Don't Work, FDA Says
A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t ...
10h
State votes on marijuana and psychedelics signal drug policy concerns
In three red states, voters opted not to legalize recreational marijuana. In blue Massachusetts, residents rejected a plan ...
2d
on MSN
FDA proposes removing ineffective decongestant found in most cold medicine
The Food and
Drug
Administration (
FDA
) is proposing to remove from the market a common ingredient found in most oral over ...
1d
FDA says some cold and allergy drugs have an ineffective key ingredient
There are new concerns that phenylephrine, an ingredient in common over-the-counter cold and allergy medicines is ineffective. The FDA said the ingredient is safe but many popular medicines are being ...
19m
on MSN
DEPUTIES: Man arrested on drug charges after traffic stop in Bertie County
According to the Bertie County Sheriff’s Office, at 9:19pm, deputies stopped a vehicle for a minor traffic violation. They ...
STAT
2d
How a Trump presidency could affect the FDA, the biotech industry, and its stocks
STAT's Readout LOUD podcast discusses how Trump's second term and the MAHA movement could affect FDA regulation, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback